Preparation, Characterization, and Preliminary Imaging Study of [¹⁸⁸Re]Re-Ibandronate as a Novel Theranostic Radiopharmaceutical for Bone Metastasis

Table 1

The in vitro stability of [¹⁸⁸Re]Re-IBA under different methods.

Method	1 h (%)	3 h (%)	6 h (%)	12 h (%)	24 h (%)
0.9% NaCl	98.14 ± 0.2	97.82 ± 0.6	96.99 ± 1.3	95.33 ± 1.1	91.44 ± 0.8
Serum	99.01 ± 0.5	98.67 ± 0.9	98.15 ± 0.8	96.90 ± 1.4	93.06 ± 1.6